Sunday, December 21, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyst Reaffirms Neutral Rating on Black Stone Minerals with Increased Price Target

Elaine Mendonca by Elaine Mendonca
March 7, 2024
in Breaking News
0
Finance_ stocks to buy
0
SHARES
4
VIEWS
Share on FacebookShare on Twitter

On March 7, 2024, Piper Sandler analyst Mark Lear reaffirms his Neutral rating on Black Stone Minerals (NYSE: BSM) while increasing the price target from $16 to $17. Lear’s updated outlook on the company’s performance is reflected in this adjustment. It is worth mentioning that the average price target for Black Stone Minerals stands at $19.00, with projections ranging from $17.00 to $21.00. There have also been cases where the price target was revised down to $15, showcasing the diverse opinions on the company’s valuation and future potential.

BSM Stock Shows Positive Momentum with 0.32% Rise on March 7, 2024: Investors Remain Cautiously Optimistic

On March 7, 2024, BSM stock showed some positive momentum as it experienced a slight increase in its price. BSM shares closed at $15.44, marking a $0.05 increase since the market last closed, representing a 0.32% rise in the stock price.

In pre-market trading, BSM stock rose an additional $0.04, indicating that investors may have a positive outlook on the company’s performance and potential for growth.

Investors should conduct thorough research and analysis before making any investment decisions, as market conditions can change rapidly. It is essential to stay informed and updated on the latest developments that may impact stock performances.

BSM stock showed promising signs on March 7, 2024, with a steady increase in its price. Investors will be closely monitoring the stock’s performance in the coming days to see if this positive momentum continues.

BSM Stock Performance Analysis: Revenue Decline but Net Income Increases

On March 7, 2024, BSM stock showed mixed performances based on the financial data provided by CNN Money. The company’s total revenue for the past year was $501.10 million, which decreased by 36.11% compared to the previous year. However, the total revenue remained flat since the last quarter at $136.38 million.

In terms of net income, BSM reported a net income of $422.55 million for the past year, which represented an 11.32% decrease compared to the previous year. On the other hand, the net income for the last quarter was $147.65 million, showing a significant increase of 137.88% since the previous quarter.

Earnings per share (EPS) for BSM stock was $1.88 for the past year, reflecting a 7.5% decrease compared to the previous year. The EPS remained flat since the last quarter at $0.65.

Overall, BSM stock showed a decline in total revenue and net income compared to the previous year. However, the company managed to increase its net income significantly since the last quarter. The EPS remained stable since the last quarter, indicating a potential stabilization in the company’s financial performance.

Tags: BSM
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Renewable energy

Analyst Reiterates Overweight Rating and Increases Price Target for Chord Energy NASDAQ CHRD

Analyst Reaffirms Buy Rating and Price Target for Mayville Engineering

Pharmaceutical Markets and money

Novo Nordisks Amycretin A GameChanger in Weight Loss Treatment

Recommended

JD.com Stock

Pivotal Week Ahead for JD.com as Major European Acquisition and EV Launch Converge

2 months ago
Snowflake Stock

Snowflake Faces Investor Confidence Test After Executive’s Rogue Forecast

2 months ago
Fiserv Stock

Fiserv’s Strategic Expansion Meets Legal Scrutiny

3 months ago
Does_Walmart_Take_Google_Pay

Does Walmart Take Google Pay? Exploring Walmart’s Exclusive Payment Solution

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin ASML BioNTech Bitcoin Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Intellia Therapeutics Faces Mounting Analyst Scrutiny Amid Regulatory Setback

Strategy Inc. Faces a Critical Index Classification Decision

DeFi Technologies Broadens Global Reach with New Listings and Products

Barrick Gold Secures Key Resolution in Mali, Paving Way for Mine Restart

Analyst Upgrade Sends Red Cat Shares Soaring

A Billion-Dollar Vote of Confidence for Standard Lithium

Trending

Tesla Stock
Automotive & E-Mobility

Tesla’s Valuation Faces Crucial Test Amid Legal Victory and Robotaxi Push

by Dieter Jaworski
December 21, 2025
0

Tesla shares are trading near their 52-week high as the company approaches a pivotal week, fueled by...

Wolfspeed Stock

Wolfspeed Secures Financial and Strategic Milestones

December 21, 2025
Textron Stock

Textron Stock Approaches Annual Peak Amid Strategic Wins

December 21, 2025
Intellia Therapeutics Stock

Intellia Therapeutics Faces Mounting Analyst Scrutiny Amid Regulatory Setback

December 21, 2025
Strategy Stock

Strategy Inc. Faces a Critical Index Classification Decision

December 21, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Tesla’s Valuation Faces Crucial Test Amid Legal Victory and Robotaxi Push
  • Wolfspeed Secures Financial and Strategic Milestones
  • Textron Stock Approaches Annual Peak Amid Strategic Wins

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com